Browsing Tag
dostarlimab
3 posts
Elevation Oncology strengthens cancer drug pipeline as cash reserves hit $93m
Elevation Oncology, Inc. has released its financial results for the fourth quarter and full-year 2024, outlining significant progress…
GSK secures expanded approval for Jemperli from FDA: A major advancement in endometrial cancer treatment
In a landmark decision, the US Food and Drug Administration (FDA) has extended its approval of Jemperli (dostarlimab)…
GSK completes $5.1bn acquisition of Tesaro to boost oncology pipeline
GlaxoSmithKline (GSK), the British pharmaceutical powerhouse, has successfully concluded its $5.1 billion acquisition of Tesaro, a leading oncology-focused…